08/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

08/2023

Aug 20, 2023, 07:27 | Insight
Rémy Duléry: Reducing PT-Cy total dose to 70 mg/kg was associated with...
Quoting Rémy Duléry, Professor of Hematology at Sorbonne University, Saint-Antoine Hospital in Paris, on LinkedIn:…
Aug 20, 2023, 07:25 | Blog
Andrea Feigl: The Health Finance Institute will be joining in a strategic partnership with the Access to Oncology Medicines (ATOM) Coalition.
Andrea Feigl, Founder & CEO of Health Finance Institute, shared on Twitter: ''I’m excited to…
Aug 19, 2023, 20:45 | Blog
Yolonda Richardson: Campaign for Tobacco-Free Kids is working with our partners around the world to identify the next generation of tobacco control champions and equip them with the tools to take down Big Tobacco.
Aug 19, 2023, 20:05 | Insight
Why patients with triple negative breast cancer respond differently to treatment. - The Institute of Cancer Research
The Institute of Cancer Research, made the following remark on Twitter: "Our scientists have looked into…
Aug 19, 2023, 19:52 | Blog
Sarah Louden: Our explosive growth is fueled by the company's mission to arm cancer care teams, as well as people living with cancer, with the latest research and strategies.
Aug 19, 2023, 19:19 | Opinion
Armen Asatryan: "Accelerated Approval". This is, in my experience, probably one of the biggest misnomers in the United States pharma regulatory world.
Quoting  Armen Asatryan, Founder & CEO, iClinDev Consulting on LinkedIn: " 'Accelerated Approval'. This is,…
Aug 19, 2023, 19:17 | Blog
Roselle De Guzman: Volunteer service and dedicated teams create impactful change!
Quoting Roselle De Guzman, Associate Professor at the Manila Central University-FDTMF Hospital in the Philippines,…
Aug 19, 2023, 19:11 | Blog
Gustaf Salford: It was an honor to host the Swedish Minister for Health Care, Acko Ankarberg Johansson, at Elekta’s Stockholm office.
Gustaf Salford, the President and CEO at Elekta, wrote in a recent post: ''It was…
Aug 19, 2023, 19:07 | Insight
Matthias Guckenberger: First esophageal cancer patient enrolled into randomized protect trial.
Matthias Guckenberger, the Chairman and a Professor of the Department of Radiation Oncology at the…
Aug 19, 2023, 19:05 | Career
Estela Rodriguez: Honored and excited to start working as social media editor for the Journal of the National Cancer Institute.
Quoting Estela Rodriguez on Twitter: ”Honored and excited to start working this month as social…
All: 539 Posts: 221 - 230